company background image
2RY0 logo

China SXT Pharmaceuticals DB:2RY0 Stock Report

Last Price

€0.29

Market Cap

€1.1m

7D

-16.0%

1Y

-81.5%

Updated

23 Dec, 2024

Data

Company Financials

China SXT Pharmaceuticals, Inc.

DB:2RY0 Stock Report

Market Cap: €1.1m

2RY0 Stock Overview

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. More details

2RY0 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

China SXT Pharmaceuticals, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for China SXT Pharmaceuticals
Historical stock prices
Current Share PriceUS$0.29
52 Week HighUS$3.42
52 Week LowUS$0.28
Beta1.12
1 Month Change-17.35%
3 Month Change-51.65%
1 Year Change-81.46%
3 Year Change-99.88%
5 Year Change-99.98%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

2RY0DE PharmaceuticalsDE Market
7D-16.0%-2.2%-2.0%
1Y-81.5%-15.8%6.8%

Return vs Industry: 2RY0 underperformed the German Pharmaceuticals industry which returned -15.6% over the past year.

Return vs Market: 2RY0 underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is 2RY0's price volatile compared to industry and market?
2RY0 volatility
2RY0 Average Weekly Movement19.7%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.4%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 2RY0's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 2RY0's weekly volatility has decreased from 26% to 20% over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
200575Albert Zhouwww.sxtchina.com

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands.

China SXT Pharmaceuticals, Inc. Fundamentals Summary

How do China SXT Pharmaceuticals's earnings and revenue compare to its market cap?
2RY0 fundamental statistics
Market cap€1.07m
Earnings (TTM)-€2.98m
Revenue (TTM)€1.85m

0.6x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2RY0 income statement (TTM)
RevenueUS$1.93m
Cost of RevenueUS$1.37m
Gross ProfitUS$553.97k
Other ExpensesUS$3.65m
Earnings-US$3.10m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.89
Gross Margin28.73%
Net Profit Margin-160.67%
Debt/Equity Ratio24.8%

How did 2RY0 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 02:11
End of Day Share Price 2024/12/23 00:00
Earnings2024/03/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China SXT Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution